Related Experiment Video
Updated: Aug 19, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
[Characteristics of arterial hypertension in obesity]
1Institut za interne bolesti, Klinika za endokrinologiju, dijabetes i bolesti metabolizma, Klinicki centar Novi Sad, Novi Sad.
Insights
Obesity-related arterial hypertension is linked to metabolic factors like insulin resistance. Treatment involves diet, exercise, and specific medications targeting these metabolic pathways.
Area of Science:
- Cardiovascular Medicine
- Metabolic Syndrome
- Obesity Research
Context:
- Arterial hypertension is highly prevalent in obese individuals.
- Hypertension in obesity can lead to left ventricular hypertrophy, diastolic dysfunction, arrhythmias, and atherosclerosis.
- Hemodynamic changes and metabolic factors, particularly insulin resistance and hyperinsulinism, are implicated in its pathogenesis.
Purpose:
- To highlight the metabolic underpinnings of arterial hypertension in obesity.
- To outline a treatment strategy informed by the metabolic basis of this condition.
Summary:
- Arterial hypertension in obese individuals is frequently associated with cardiovascular complications.
- Metabolic factors, especially insulin resistance and hyperinsulinism, are now considered primary drivers of hypertension in obesity, earning it the term 'metabolic hypertension'.
- Treatment strategies emphasize lifestyle modifications (diet, reduced salt intake, physical activity) and pharmacotherapy including ACE inhibitors, alpha-1 blockers, and calcium channel blockers.
Impact:
- Informed therapeutic approaches for metabolic hypertension in obesity.
- Potential for improved cardiovascular outcomes in obese hypertensive patients.
- Enhanced understanding of the link between metabolic health and cardiovascular disease.
Introduction:
Arterial hypertension is the most frequent cardiovascular disease in obese persons, progressing with time to left ventricular hypertension, often associated with dilatation, diastolic disorders, hearth rhythm disturbance, and generalized atherosclerosis.
Etiology:
The origin of this disease is related to hemodynamic disturbances (increased blood volume, minute volume, mainly due to increased stroke volume) accompanied with changes of peripheral resistance, which increases in a later phase. However, metabolic factors are presently considered as primarily responsible for appearance of hypertension, which has rightly obtained the attribute of metabolic hypertension. A key role belongs to insulin, in fact, to insulin resistance and hyperinsulinism.
Treatment:
Awareness of the metabolic basis of arterial hypertension in obesity has resulted in a specific approach to its treatment. The primary treatment includes reduction diet, with a drastic reduction of salt intake and with compulsory physical activity, while concerning medications one should consider converting enzyme inhibitors, alpha1 blockers and calcium channel antagonists.
Related Concept Videos
Obesity
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Drug Dosing: Obese Patients
Hypertension I: Introduction
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution